Enterome Bioscience, a French pioneer in the development of innovative disease management solutions based on understanding of the gut microbiome, has appointed Alessandra Cervino as Head of Discovery.
Cervino has more than 15 years of experience in the discovery and development of genetic and genomic biomarkers, and has for the past year been a consultant to Enterome in relation to its core technologies. As Head of Discovery, she will lead a team of bioinformaticians and biostatisticians to deepen the company’s understanding of the gut microbiome through a metagenomics approach with the goal of developing a new generation of disease biomarkers, companion diagnostics products and new therapies.
Before joining Enterome, Cervino was VP R&D and Biostatistics at TCLand expression, a personalised medicine company developing companion diagnostics and biomarkers for immune disorders and transplantation.
Before that she was Head of Statistical Sciences and Assistant Professor at Scripps Florida, where she conducted the first genome-wide study of lupus and developed an innovative workflow that combines genotypic and transcriptomic data to identify novel genes. She was the first group leader in statistical genetics at Rosetta Inpharmatics/Merck in the US, where she played a pioneering role in translating genetic research into new drug targets and pharmacogenomic programmes.
